PLoS neglected tropical diseases · 2023 · 12 citations · 36 references
Life SciencesImmunologyInfectious DiseasesInnate ImmunityMolecular VirologyVirologyAntiviral ImmunityInnate Immune ActivationInnate Immune ResponseInnate Immune Signaling PathwaysInterferon ResponsesViral PathogenesisAntiviral Interferon ResponsesHand-foot-mouth DiseaseInhibition Of Interferon ResponsesInterferon Response To Viral InfectionIrf3 SignalingType I Interferon PathwaysType I Interferon ResponsesViral Therapeutic Targets
BACKGROUND: Enterovirus A71 (EV-A71) is an important causative agent of hand-foot-and-mouth disease (HFMD) associated with enormous healthcare and socioeconomic burden. Although a range of studies about EV-A71 pathogenesis have been well described, the underlying molecular mechanism in terms of innate immune response is still not fully understood, especially the roles of TANK-binding kinase 1 (TBK1) and interferon-regulatory factor 3 (IRF3). METHODOLOGY/PRINCIPAL FINDINGS: Here, we applied TBK1 inhibitor and IRF3 agonist, for the first time, to evaluate the antiviral activities of TBK1 and IRF3 in vivo. We found that, through regulating EV-A71-induced type I interferon (IFN) response, IRF3 agonist effectively alleviated EV-A71-induced illness, while TBK1 inhibitor aggravated disease progression. In addition, EV-A71 replication was suppressed in EVA-71-infected mice administrated with IRF3 agonist. On the other hand, more severe pathological alterations of neuronal degeneration, muscle fiber breaks, fractured or fused alveolar walls, and diffuse congestion occurred in EVA-71-infected mice treated with TBK1 inhibitor administration. Furthermore, we determined the concentrations of interleukin (IL)-6, tumor necrosis factor-alpha (TNF-α), IL-1β, monocyte chemotactic protein-1 (MCP-1), and IL-10 in both lungs and brains of mice and found that TBK1 inhibitor promoted EV-A71-induced inflammatory response, while IRF3 agonist alleviated it, which was consistent with clinical manifestations and pathological alterations. CONCLUSIONS: Collectively, our findings suggest that TBK1 and IRF3 are potential therapeutic targets in EV-A71-induced illness.
36
Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation
Siqi Liu, Xin Cai, Jiaxi Wu et al. · Science · 2015 · 1.9K citations
Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response
Gagik Oganesyan, Supriya K. Saha, Beichu Guo et al. · Nature · 2005 · 863 citations
Enterovirus 2A <sup>pro</sup> Targets MDA5 and MAVS in Infected Cells
Feng Qian, Martijn A. Langereis, Marie Lork et al. · Journal of Virology · 2014 · 216 citations · Full text
Xiaobo Lei, Xinlei Liu, Yijie Ma et al. · Journal of Virology · 2010 · 211 citations · Full text